Novartis' Zolgensma study halted by FDA amid safety questions

U.S. regulators have halted a trial of Novartis's Zolgensma treatment after an animal study raised safety concerns, the company said on Wednesday, in a setback for the drugmaker's plan to expand its use to older patients.

from Reuters: Health News https://ift.tt/2N0H0RU
https://ift.tt/xePdMM